Based on the decapeptide structure of natural GnRH, Gonadorelin Acetate Peptide has enhanced water solubility and bioavailability through acetate modification, while fully retaining the physiological activity of natural GnRH with both safety and controllable efficacy. It is a commonly used regulatory tool for the hypothalamic-pituitary-gonadal axis in clinical practice and scientific research.
With excellent water solubility and convenient administration via subcutaneous or intravenous injection, this peptide is widely applied in reproductive health regulation, ovulation induction for assisted reproduction, pituitary function diagnosis, and basic research on hormone-related diseases. It can serve as a clinical therapeutic drug to correct endocrine disorders and also as a research tool to explore hormone regulatory mechanisms, making it a distinctive peptide with both physiological properties and practical value.
Our Products Form






Gonadorelin Acetate COA



In the field of veterinary medicine, Gonadorelin Acetate Peptide is widely used for reproductive function regulation, treatment of reproductive disorders, optimization of assisted reproductive technologies and diagnosis of related diseases, relying on its function of precisely regulating sex hormone secretion. It has become a core polypeptide veterinary drug for improving the breeding efficiency of livestock and poultry and safeguarding animal reproductive health.
Veterinary Adaptability Characteristics
The wide application of the product in veterinary medicine stems from its high homology with animal endogenous GnRH and the advantages of acetate modification, which adapts to the physiological needs of livestock, poultry and economic animals. It features a clear and mild mechanism of action: after intramuscular or intravenous injection, it is rapidly absorbed by the animal body, specifically binds to pituitary GnRH receptors, and accurately stimulates the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby regulating the functions of gonads (ovaries and testes) and achieving bidirectional regulation of sex hormone secretion. It can not only supplement the driving force for hormone regulation in animals with hypogonadism, but also solve the problem of reproductive rhythm disorder by precisely regulating hormone peaks.
Compared with other veterinary reproductive hormone drugs, its core advantages are reflected in three aspects: first, high safety-consistent with the structure of the animal's own hormones, it is less likely to cause adverse reactions such as allergy and hormonal disorder, with only a small number of animals experiencing transient swelling at the injection site which can subside spontaneously; second, convenient administration-mostly prepared as a sterile injection solution (the common specification is 100μg/ml), it can be administered by intramuscular or intravenous injection with simple operation, suitable for large-scale breeding; third, strong targeting-the dosage can be adjusted according to the animal species, body weight and disease conditions, without excessive worry about cross-reactivity, and it is applicable to a variety of livestock and poultry such as cattle, horses, sheep and pigs, which is also the core premise for its popular application in veterinary medicine.

Applications in Cattle Breeding
Cattle (especially dairy cows and beef cattle) are the most widely applicable animal category for it, with its application focused on the treatment of reproductive disorders, regulation of estrus synchronization and assistance in artificial insemination, which is directly related to breeding economic benefits. The specific application scenarios are as follows:
Treatment of Ovarian Follicular Cysts in Dairy Cows
Ovarian follicular cysts are a common reproductive disorder in dairy cows, mostly caused by failure of normal ovulation after follicular maturation and incomplete luteinization. The clinical manifestations include irregular estrus and nymphomania (frequent estrus without regularity) in dairy cows, which seriously affects the lactation cycle and conception rate. Without timely treatment, it will lead to decreased reproductive performance and increased breeding costs of dairy cows. Gonadorelin Acetate Peptide is one of the first-choice drugs for the treatment of this disease. Its mechanism of action is to stimulate the pituitary to release endogenous LH, promoting ovulation and luteinization of cystic follicles, thus restoring the normal ovarian function.
Different from exogenous LH supplementation, it is more in line with the own physiological rhythm of dairy cows with more stable therapeutic effects.In clinical practice, the administration regimen is clear: the dosage for each dairy cow is 100μg (corresponding to 1ml sterile injection solution) per time, which can be administered by intravenous or intramuscular injection. A single administration can achieve the ideal therapeutic effect with a cure rate of over 85%. Most dairy cows can resume normal estrus 3-7 days after administration, with a significant increase in subsequent conception rate. Compared with traditional therapeutic drugs, the product does not require multiple administrations and has no impact on the milk yield and milk quality of dairy cows, suitable for the diagnosis and treatment needs of large-scale dairy farms, and it is one of the core drugs for reproductive health management of dairy cows.
Assistance in Cattle Estrus Synchronization and Fixed-Time Artificial Insemination (FTAI)
For both large-scale dairy cow breeding and beef cattle reproduction, the regulation of estrus synchronization is a key means to improve breeding efficiency, which can realize centralized artificial insemination, centralized calving and centralized feeding management, reducing the labor cost of breeding. It is often used in combination with cloprostenol sodium to construct a standardized estrus synchronization program, adapting to the breeding needs of lactating dairy cows and beef cows.
At present, the mainstream synchronization program is divided into three steps: Step 1, on the start day of the program (Time 0), intramuscularly inject 1ml Gonadorelin Acetate injection (100μg) to each cow to initiate synchronous follicular development; Step 2, 6-8 days after the first injection, intramuscularly inject 500μg cloprostenol sodium to promote luteolysis and induce the onset of estrus; Step 3, 30-72 hours after the injection of cloprostenol sodium, intramuscularly inject 1ml Gonadorelin Acetate injection to each cow for the second time to accurately induce ovulation and ensure synchronous follicular maturation. Fixed-time artificial insemination can be carried out within 0-24 hours after the second injection, or conventional insemination can be performed after the detection of estrus.
This program can make the estrus synchronization rate of the cattle herd reach over 90% and increase the conception rate of artificial insemination by 15%-20%, effectively solving the problems of scattered estrus, missed insemination and incorrect insemination in the cattle herd. It is especially suitable for scenarios such as delayed postpartum estrus in lactating dairy cows and large-scale reproduction of beef cattle, greatly improving the reproductive efficiency of the cattle herd and reducing the breeding management cost. In addition, for dairy cows with ovarian dysfunction after calving, this synchronization program can be initiated about 50 days after calving to help dairy cows quickly restore reproductive function and shorten the calving interval.
Applications in Other Livestock and Poultry such as Horses and Sheep
In addition to cattle, the product also has important applications in the reproductive management of other livestock and poultry such as horses and sheep, with its core focus on ovulation induction and estrus regulation. It adapts to their reproductive physiological characteristics and solves the reproductive problems in breeding.
Applications in Horse Breeding
Horses have a long reproductive cycle and complex estrus rules. Especially for racehorses and breeding stallions, reproductive performance is directly related to breeding value. It is mainly used for ovulation induction in horses to help solve the problems of delayed ovulation and irregular ovulation and improve the success rate of breeding. In clinical application, for mares in estrus, when the follicle develops to a diameter of 4-5cm (mature follicle), intramuscular injection of 100μg Gonadorelin Acetate injection can induce ovulation in mares within 24-48 hours, accurately controlling the breeding time and avoiding breeding failure caused by delayed ovulation.
In addition, for some mares with estrus arrest caused by hypothalamic dysfunction, it can awaken the pituitary secretory function by simulating the pulsatile secretion of GnRH, stimulate the release of FSH and LH, and help mares restore the normal estrus cycle. It is especially suitable for the conditioning of reproductive function of breeding stallions, ensuring the breeding efficiency of breeding stallions and providing reproductive health protection for the breeding of racehorses and breeding stallions.
Applications in Sheep Breeding
In the large-scale breeding of sheep (sheep and goats), estrus synchronization and ovulation induction are the keys to improving breeding efficiency. It can effectively solve the problems of scattered estrus and seasonal estrus restriction in sheep, adapting to the physiological characteristics of sheep and goats. In the regulation of estrus synchronization, the synchronization program for cattle can be referred to, and the product can be used in combination with cloprostenol sodium with dosage adjusted according to the body weight of sheep (the dosage for each sheep is 50-100μg per time), which can make the estrus synchronization rate of the sheep flock reach over 85%, facilitating centralized breeding and feeding management.
At the same time, for sheep with seasonal estrus, Gonadorelin Acetate Peptide can break the seasonal reproductive inhibition by stimulating the pituitary to secrete gonadotropins in the non-estrus period, induce sheep to estrus in advance, extend the breeding cycle and increase the number of lambing. In addition, for goats with ovulation disorders, a single intramuscular injection of 100μg it can effectively induce ovulation of mature follicles, improve the conception rate of breeding, reduce the non-pregnancy rate, and help improve the benefits of large-scale goat breeding.

Core Synthesis Process
The mainstream industrial production adopts Boc solid-phase peptide synthesis technology. With specific resin as the starting material, Boc-amino acid derivatives and pGlu as monomers, and HOAT/DCCI composite condensing agent as the coupling reagent, the reaction is precisely controlled at a molar ratio of 1.5∶2∶2∶1. The steps of peptide coupling, deprotection and neutralization are completed step by step, and the crude product is finally obtained by ammonolysis and resin cleavage. This process balances product yield and cost control, adapting to the synthesis requirements of its decapeptide structure.

Purification and Salt Conversion Treatment
The crude product is purified by reversed-phase high-performance liquid chromatography (HPLC), with impurities removed by gradient elution to increase the purity to over 99.0%. After purification, the HPLC salt conversion method is adopted with ammonium acetate buffer solution for acetate conversion. Then the product is subjected to reduced pressure concentration, acetone precipitation and freeze-drying to obtain the powdered finished product, which ensures water solubility and stability, adapts to the processing requirements of veterinary injection preparations, and avoids the risk of solvent residue at the same time.

Key Quality Control Points
The entire process complies with the standards for veterinary polypeptide veterinary drugs, with a focus on controlling the accuracy of amino acid sequence and purity, detected by HPLC at a wavelength of 220nm. The parameters such as synthesis temperature and washing process are strictly controlled, the process conditions of ammonolysis, precipitation and other steps are standardized, and the raw material residue and sterility are managed at the same time to ensure that the finished product contains no harmful impurities, adapts to the administration needs of various livestock and poultry, and balances safety and biological activity.
FAQ
Why do men take gonadorelin acetate?
+
-
We most commonly prescribe gonadorelin for men who are on TRT and are primarily concerned about testicular size, scrotal fullness, or the cosmetic effects of testicular shrinkage, rather than maintaining fertility or the ability to produce testosterone.
What are the side effects of gonadorelin acetate?
+
-
Headache, nausea, and mild abdominal pain may occur with menstrual bleeding. Injection site reactions (such as mild irritation, redness, bruising) may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
Hot Tags: gonadorelin acetate peptide, China gonadorelin acetate peptide manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, prilocaine felypressin, glp1 shot, etelcalcetide structure

